Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the Randomized Clinical Trial: NCCTG N9831 (Alliance) Study

BACKGROUND: The goal of this study was to assess the impact of trastuzumab on locoregional failure. METHODS: The analysis included 2763 patients with HER2-positive (HER2+) breast cancer who were randomly assigned to adjuvant doxorubicin (A), cyclophosphamide (C), paclitaxel (T) and trastuzumab (H) (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Vargas, Carlos E., Thorpe, Cameron S., Dueck, Amylou C., Tenner, Kathleen S., Davidson, Nancy E., Martino, Silvana, Pisansky, Thomas M., Hwang, E. Shelley, Halyard, Michele Y., Pockaj, Barbara A., Perez, Edith A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686244/
https://ncbi.nlm.nih.gov/pubmed/32931029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados